Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mycronic | MLT | Nov 28, 2024 | 33.44 | -1.65 |
Mydecine Innovations Group Inc | 0NF0 | Nov 28, 2024 | 0.00 | +16.67 |
MYECO GROUP LTD | MZ60 | 0.00 | 0.00 | |
Myer Holdings Ltd | 30M | Nov 28, 2024 | 0.61 | 0.00 |
Myers Industries, Inc. | MJF | Nov 28, 2024 | 10.90 | +4.81 |
MYHEALTHCHECKED LS -,015 | 0I10 | Nov 28, 2024 | 0.13 | 0.00 |
MYHOTELMATCH EO 1,- | 6GD0 | Nov 28, 2024 | 0.42 | 0.00 |
Mynaric ADR | M0YA | Nov 28, 2024 | 1.22 | +3.39 |
MYNARIC AG NA O.N. | M0YN | Nov 28, 2024 | 5.02 | +1.41 |
Mynd.Ai | WK6 | Nov 28, 2024 | 2.08 | +30.00 |
Myomo Inc. | 0M61 | Nov 28, 2024 | 4.87 | -1.52 |
MYR Group, Inc. | MYP | Nov 28, 2024 | 149.00 | -1.32 |
Myriad Genetics, Inc. | MYD | Nov 28, 2024 | 15.20 | 0.00 |
MYRIAD URANIUM CORP. | C3Q | Nov 28, 2024 | 0.33 | +0.62 |
Mytilineos S.A. | MYH | Nov 28, 2024 | 31.28 | +0.13 |
N Brown Group PLC | BGUA | Nov 28, 2024 | 0.45 | -0.89 |
N4 Pharma plc. | 0GO | Nov 28, 2024 | 0.00 | 0.00 |
Naas Technology ADR | 6RE | Nov 28, 2024 | 2.60 | -0.76 |
Nabaltec AG | NTG | Nov 28, 2024 | 13.85 | -3.15 |
Nabors Industries Ltd | NBI1 | Nov 28, 2024 | 68.50 | -1.44 |
Nabtesco Corp. | 3N8 | Nov 28, 2024 | 14.90 | +2.05 |
Nachi-Fujikoshi Corp. | 8UM | Nov 28, 2024 | 18.90 | -2.58 |
Nacon S.A. | 4AW | Nov 28, 2024 | 0.48 | -3.14 |
Nafco Co | 64E | Nov 28, 2024 | 12.10 | +1.68 |
NAGACORP | N9J | Nov 28, 2024 | 0.35 | -1.83 |
Nagambie Resources Limited | P6C | Nov 28, 2024 | 0.01 | -5.26 |
Nagarro SE | NA9 | Nov 28, 2024 | 98.30 | -0.91 |
NAGASE + CO. LTD | P22 | Nov 28, 2024 | 18.75 | 0.00 |
Nagoya Railroad Co. Ltd | 59V | Nov 28, 2024 | 10.50 | +0.96 |
Nakanishi Inc. | 6SN | Nov 28, 2024 | 14.30 | +0.70 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.